Abbott Laboratories’s Diet Drug Meridia Study Shows Drug Raises Heart Attack, Stroke Risk; Renews Calls For U.S. Ban

WASHINGTON, Sept 1 (Reuters) - A study funded by Abbott Laboratories (ABT.N) offered more detailed evidence that its weight-loss drug Meridia increases heart risks, prompting renewed calls by consumer advocates and others to pull the drug from the market.